| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $3.0B | — |
| Cost of Revenue | — | — | — | — | — | $2.0B | $2.5B | $2.7B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.5B | $0.1B | $0.2B | $0.3B | $-0.0B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.3B | $0.0B | $0.1B | $0.1B | $-0.0B | $0.3B | $0.3B |
| EPS (Basic) | $10.62 | $8.02 | $0.78 | $1.44 | $2.22 | $-0.93 | $1.44 | $1.30 |
| EPS (Diluted) | $10.35 | $7.77 | $0.77 | $1.44 | $2.20 | $-0.93 | $1.43 | $1.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.4B | $7.1B | $7.0B | $7.4B | $7.1B | $6.9B | $6.7B | $6.3B |
| Current Assets | $1.1B | $1.1B | $1.1B | $1.4B | $1.1B | $1.0B | $0.8B | $1.0B |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $0.1B | $0.3B | $0.2B | $0.1B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.7B | $1.4B | $1.3B | $1.2B | $1.2B | $0.9B | $0.9B | $0.9B |
| Stockholders' Equity | $2.7B | $2.4B | $2.1B | $2.3B | $2.3B | $2.1B | $2.2B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.7B | $0.7B | $0.5B | $0.8B | $0.6B | $0.7B | $0.8B |
| Investing Cash Flow | $-0.7B | $-0.2B | $-0.0B | $-0.9B | $-0.7B | $-0.7B | $-0.7B | $-1.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.4B | $-0.4B | $-0.7B | $0.3B | $-0.1B | $0.2B | $-0.3B | $0.3B |